Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Within the cohort, 4.5% of participants in the semaglutide group and 0.8% of participants in the placebo group discontinued treatment due to gastrointestinal events
FAQs about Oral Semaglutide Yes
Notes: This product is not recommended for individuals under 18 years of age or for pregnant or breastfeeding women
Originally developed for type 2 diabetes, it has also been FDA-approved for chronic weight management, demonstrating significant, sustained weight loss in clinical trials
US$ 28.85
US$ 22.83
US$ 25.47
